Elon Musk's brain-computer interface (BCI) company Neuralink has been given the green light to test its device in tetraplegic patients in Canada – the first international trial of the technology.

Precision Neurosciences has closed an impressive $102 million investment round as it races with Elon Musk's Neuralink and others to bring brain-computer interface (BCI) technology to the market.

We preselected all newsletters you had before unsubscribing.

In January 2024, Elon Musk's neurotechnology company, Neuralink, conducted their first human trial. The first-ever patient was a 29-year-old man named Noland Arbaugh, who had been paralyzed.